Jobs
-
Moat Biotechnology (MoatBio), a spin-out from Tetherex Pharmaceuticals, announced that it has closed a funding round of more than $6.5 million following an initial funding led by Cortado Ventures in September 2022. The company says that it… Read more . . .
-
Dutch device company Gilbert Technologies has announced the closing of a €7 million funding round led by DeepTechXL. The company said that Brabant Startup Funds also converted its earlier loan to Gilbert Technologies, making Brabant… Read more . . .
-
Vistagen announced that a Phase 2a trial of the company’s PH80 intranasal epoxyestrenolone in menopausal women experiencing hot flashes demonstrated statistically significant reduction in the frequency and severity of the hot flashes. The company acquired PH80… Read more . . .
-
Australian inhaled cannabis developer InhaleRx (formerly Lifespot Health) announced the initiation of a Phase 1 SAD study of the company’s IRX211 inhaled dronabinol, a synthetic THC. According to the company, IRX211 was formulated by “a… Read more . . .
-
Alpha Cognition announced that the Army Medical Research and Material Command has awarded the company a $750,000 grant to support a pre-clinical study of the possible use of ALPHA-1062 Intranasal galantamine for the treatment of blast-induced… Read more . . .
-
According to Oragenics, Canadian biopharmaceutical research consortium CQDM has awarded a grant for development of variant-agnostic protein antigens for use in an intranasal COVID-19 vaccine that “aims to build upon Oragenics’ current lead intranasal vaccine… Read more . . .
-
Aerami Therapeutics has announced the promotion of Joshua Ziel from Chief of Staff and VP, Program Development to Chief Operating Officer and interim CEO. Executive Chairwoman Anne Whitaker had been leading Aerami since the sudden… Read more . . .
-
After pausing for several years due to the COVID-19 pandemic, the 2023 edition of Aerosol School will take place virtually. Students will have access to more than 200 hours of lectures from well-known experts on… Read more . . .
-
Pneumagen said that it has closed an £8 million funding round, with proceeds going to support Phase 2 development of the company’s Neumifil multivalent carbohydrate binding module (mCBM) nasal spray, including a Phase 2b trial… Read more . . .
-
Nephron Pharmaceuticals announced that the company is now offering 0.5% albuterol sulfate inhalation solution in 5 ml vials for direct shipping to US medical facilities in response to a nationwide shortage. Ritedose Pharmaceuticals recently announced… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
June 30: RespireX 2027, Boston, MA, USA